SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-053711
Filing Date
2021-08-27
Accepted
2021-08-27 18:32:12
Documents
2
Period of Report
2021-08-25

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1540
2 POA DOCUMENT poa.txt EX-24.3_1006105 4677
  Complete submission text file 0001209191-21-053711.txt   7694
Mailing Address C/O COLUMN GROUP LP 1700 OWENS STREET, SUITE 500 SAN FRANCISCO CA 94158
Business Address
Lasky Laurence (Reporting) CIK: 0001553357 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39866 | Film No.: 211220442

Mailing Address 200 CLARENDON STREET, 51ST FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET, 51ST FLOOR BOSTON MA 02116 2157319450
eFFECTOR Therapeutics, Inc. (Issuer) CIK: 0001828522 (see all company filings)

IRS No.: 853306396 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations